Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review
Thibault Fiolet(European Food Safety Authority), Nathan Peiffer‐Smadja(Université Claude Bernard Lyon 1)
Cited by 945
Related Papers
Consumption of ultra-processed foods and cancer risk: results from NutriNet-Santé prospective cohort
|BMJ|2018|997
Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial
|The Lancet Infectious Diseases|2021|344
Neurologic manifestations associated with COVID-19: a multicentre registry
|Clinical Microbiology and Infection|2020|142